AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2015
Oct 19, 2015
32134_dirs_2015-10-19_687ea948-1724-45fb-b78d-31eaaa166cfa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2015-10-15
Reporting Person: GREER R SCOTT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-15 | Common Stock | M | 22500 | $11.34 | Acquired | 73333 | Direct |
| 2015-10-15 | Common Stock | M | 10000 | $11.34 | Acquired | 83333 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-15 | Stock Option | $11.34 | M | 22500 | Disposed | 2018-01-31 | Common Stock (22500) | Direct |
| 2015-10-15 | Stock Option | $11.34 | M | 10000 | Disposed | 2018-01-31 | Common Stock (10000) | Direct |
More from NEKTAR THERAPEUTICS
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20